Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
Healthcare & PharmaceuticalCompany Update

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

February 25, 2025 7:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, announced today that Glatt Air Techniques, Inc., part of Glatt Group, a vertically integrated pharmaceutical services company with FDA- and EU-approved sites operating under cGMP conditions, has undertaken FDA-required testing of the Company's high-dose sublingual aspirin...

Read more
Global Atherosclerosis Market Poised for Steady Growth, Projected to Reach USD 62,180.3 Million by 2035 | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Global Atherosclerosis Market Poised for Steady Growth, Projected to Reach USD 62,180.3 Million by 2035 | Future Market Insights, Inc.

February 25, 2025 7:30 AM

The global atherosclerosis market is on track to attain USD 47,637.4 million by 2025, expanding at a compound annual growth rate (CAGR) of 2.7%, reaching USD 62,180.3 million by 2035. The revenue generated by therapeutic apheresis in 2024 was approximately USD 46,430.2 million, highlighting the market's strong foothold in cardiovascular disease management.Atherosclerosis is the shrinking of a vein caused by plaque accumulation. Atherosclerosis...

Read more
CTT Pharma Gives Update On U.S. and European Patents
Healthcare & PharmaceuticalCompany Update

CTT Pharma Gives Update On U.S. and European Patents

February 25, 2025 7:15 AM

CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) has received notification of an intention to grant from the European Patent Office(EPO) for additional claims to our original European Patent. CTT Pharma already received an intention to grant from the EPO for our micelle delivery but opted to further define and strengthen our patent for diabetes related drugs. Since, the patent for the diabetes drug Liraglutide has expired CTT will seek to find...

Read more
Moderna to Present at Upcoming Conferences in March 2025
Healthcare & PharmaceuticalConferences

Moderna to Present at Upcoming Conferences in March 2025

February 25, 2025 7:00 AM

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences:TD Cowen 45th Annual Health Care Conference, on Wednesday, March 5th at 9:10am ETBarclays 27th Annual Global Healthcare Conference, on Tuesday, March 11th at 1:30pm ETA live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.Webcast:...

Read more
DOJ Makes Major Announcement - a Major Boost for MMJ'S Cannabis Research and DEA Accountability
Healthcare & PharmaceuticalCompany Update

DOJ Makes Major Announcement - a Major Boost for MMJ'S Cannabis Research and DEA Accountability

February 25, 2025 6:00 AM

In a critical development that could reshape federal administrative law, the Department of Justice (DOJ) has announced that it will no longer defend statutory protections that currently shield Administrative Law Judges (ALJs) from removal. This significant shift is expected to bolster MMJ International Holdings' ongoing lawsuit against the Drug Enforcement Administration (DEA), which has been criticized for stalling MMJ's application to...

Read more
Desert Oasis Healthcare Honored with Dual Accolades in 2024 Best of Desert Awards
Healthcare & PharmaceuticalAwards

Desert Oasis Healthcare Honored with Dual Accolades in 2024 Best of Desert Awards

February 24, 2025 8:30 PM

Desert Oasis Healthcare (DOHC) is proud to announce its recent recognition in the 2024 Best of Desert Community's Choice Awards. The organization has been awarded Best Home Health Care Services, and Nurse Practitioner Jamie Finch has been honored as Best Nurse/Nurse Practitioner.The awards ceremony celebrated the outstanding contributions of local businesses and professionals in the Palm Springs area. The nomination phase occurred July 10-31,...

Read more
UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis
Healthcare & PharmaceuticalCompany Update

UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis

February 24, 2025 8:20 PM

VANCOUVER, BC / ACCESS Newswire / February 24, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), is issuing this news release to advise its shareholders that the Company has been subject to a continuous disclosure review by the British Columbia Securities Commission. In connection therewith, the Company has filed amended and restated management's discussion and analysis ("MD&A") for the six (6) month period...

Read more
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Healthcare & PharmaceuticalCompany Update

Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile

February 24, 2025 6:00 PM

Onco-Innovations Limited(CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology"), specifically that it has demonstrated enhanced PNKP inhibitor delivery, enabling solubilization with minimal toxicity, in a June 2021 study[1] conducted by researchers at the...

Read more
Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

February 24, 2025 2:35 PM

Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation,...

Read more
TriSpan Closes Continuation Vehicle for Prestige PEO Holdings
Healthcare & PharmaceuticalCompany Update

TriSpan Closes Continuation Vehicle for Prestige PEO Holdings

February 24, 2025 12:45 PM

TriSpan LLP ("TriSpan"), a New York and London based private equity firm, is pleased to announce the closing of a single-asset continuation vehicle that acquired interests in Prestige PEO Holdings LP ("Prestige" or the "Company"). The transaction was led by growth equity firm Lead Edge Capital, and supported by a diverse group of existing investors, including a substantial investment from affiliates of TriSpan. The transaction will provide...

Read more
The Assistance Fund Opens New Program for Familial Chylomicronemia Syndrome
Healthcare & PharmaceuticalCompany Update

The Assistance Fund Opens New Program for Familial Chylomicronemia Syndrome

February 24, 2025 12:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with familial chylomicronemia syndrome. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, health insurance premiums, and incidental...

Read more
PharmPix Announces Entry Into the Medicare Market With Launch of Proprietary Innovative Technology, MedArk(TM)
Healthcare & PharmaceuticalCompany Update

PharmPix Announces Entry Into the Medicare Market With Launch of Proprietary Innovative Technology, MedArk(TM)

February 24, 2025 10:00 AM

PharmPix further positions itself as a leader in the pharmacy benefit management arena as they are proud to announce their expansion into the Medicare market with the launch of MedArk™, a transformative platform designed to meet the complex needs of Medicare Part D plans. MedArk™ offers a robust, scalable solution for managing Medicare pharmacy benefits with ease.MedArk™ is designed to meet the stringent demands of Medicare compliance while...

Read more
Acıbadem Kartal Hospital Opens in Istanbul, Becoming Group's 25th Hospital Worldwide
Healthcare & PharmaceuticalCompany Update

Acıbadem Kartal Hospital Opens in Istanbul, Becoming Group's 25th Hospital Worldwide

February 24, 2025 10:00 AM

Acıbadem Healthcare Group has opened Acıbadem Kartal Hospital, adding a new state-of-the-art facility to Istanbul's healthcare landscape. As the group's 11th hospital in Istanbul and 25th worldwide, Acıbadem Kartal Hospital welcomed its first patients on Feb. 17, 2025.With this launch, Acıbadem brings over 30 years of experience to Kartal, expanding its extensive network of 25 hospitals and 15 medical centers across five countries. The hospital...

Read more
Vacuum Blood Collection Device Market to Reach USD 5,407.56 Million by 2035, Driven by Diagnostic Demand and Innovation | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Vacuum Blood Collection Device Market to Reach USD 5,407.56 Million by 2035, Driven by Diagnostic Demand and Innovation | Future Market Insights, Inc.

February 24, 2025 10:00 AM

The global vacuum blood collection device market is projected to experience significant growth over the next decade. Valued at approximately USD 2,898.38 million in 2025, the market is expected to reach USD 5,407.56 million by 2035, registering a compound annual growth rate (CAGR) of 6.4% during the forecast period.This growth trajectory is primarily attributed to the increasing prevalence of chronic and infectious diseases worldwide. Conditions...

Read more
Agape ATP Corporation Signs ICPO with Swiss One Oil & Gas AG for 200,000 MT of EN590 and 2,000,000 Barrels of Jet Fuel A1
Healthcare & PharmaceuticalCompany Update

Agape ATP Corporation Signs ICPO with Swiss One Oil & Gas AG for 200,000 MT of EN590 and 2,000,000 Barrels of Jet Fuel A1

February 24, 2025 9:30 AM

NASDAQ-listed AGAPE ATP Corporation ("ATPC") signed an Irrevocable Corporate Purchase Order ("ICPO") with Swiss One Oil & Gas AG ("Swiss One") and entered into a strategic partnership to enhance oil and gas sales and purchase operations. The ICPO entails the procurement of approximately 200,000 metric tons of EN590 10PPM diesel and 2,000,000 barrels of Jet Fuel A1 for an initial trial phase. This collaboration brings together ATPC's expertise in...

Read more
Ankle & Foot Centers of America Highlights Critical Link Between Foot Health and Heart Health
Healthcare & PharmaceuticalCompany Update

Ankle & Foot Centers of America Highlights Critical Link Between Foot Health and Heart Health

February 24, 2025 9:01 AM

Persistent pain, swelling or non-healing wounds in the legs and feet are reasons to see a podiatrist, but they also may be the body's way of raising the red flag on circulatory issues. During American Heart Month, Ankle & Foot Centers of America is reminding patients and healthcare providers that vascular and circulation assessments by a podiatrist can provide early detection of serious cardiovascular issues.Ankle & Foot Centers of America, one...

Read more
BioNxt Solutions Announces Debenture Unit Financing
Healthcare & PharmaceuticalFinancing

BioNxt Solutions Announces Debenture Unit Financing

February 24, 2025 9:00 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), announces a non-brokered private placement of debenture units (the "Debenture Units") with each unit consisting of $0.50 in principal amount of debenture bearing interest at a rate of 8.0% per annum for a period of two years following the closing date (the "Debenture"), convertible into a common share in the capital of the Company (a "Common Shares"), and one...

Read more
Bionic Bloom Named Best Mental Health Clinic - What’s Next?
Healthcare & PharmaceuticalProduct Announcements

Bionic Bloom Named Best Mental Health Clinic - What’s Next?

February 24, 2025 9:00 AM

Bionic Bloom, the nation's first legal plant medicine therapy center and a leader in integrative mental health, has been awarded the People's Choice Award for Best Mental Health Clinic in the Best of the Bay awards. This recognition highlights Bionic Bloom's groundbreaking approach to therapy, blending cutting-edge psychedelic medicine, empowerment-based neurodivergent care, and holistic wellness practices."We are honored to be recognized as the...

Read more
Building to Meet the Need for Care During Mental Health Crisis
Healthcare & PharmaceuticalCompany Update

Building to Meet the Need for Care During Mental Health Crisis

February 24, 2025 7:00 AM

Spring Lake Ranch Therapeutic Community has publicly launched an $18MM Capital Campaign. Funding will support the renovation and expansion of facilities as well as new programming for longer-term care at a lower price point.Spring Lake Ranch (SLR) is a 501(c)3 nonprofit that serves adults struggling with mental health and substance use challenges. Residents live in a community setting, where they receive psychiatric support combined with a...

Read more
Launch of Dosell Sales in Spain - A Groundbreaking Solution to Improve Medication Adherence
Healthcare & PharmaceuticalCompany Update

Launch of Dosell Sales in Spain - A Groundbreaking Solution to Improve Medication Adherence

February 24, 2025 6:10 AM

iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") proudly announces the sales launch of Dosell in Spain through a strategic partnership with Ti-Medi, a leading player in pharmaceutical technology in Southern Europe. The launch and commercialization of Dosell, under the brand name Savioo Home, mark a significant milestone in the effort to enhance medication adherence and improve the quality of life for patients with chronic...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?